Webster NJ - Search Results

1

Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice.

Sen S, Langiewicz M, Jumaa H, Webster NJ. Sen S, et al. Among authors: webster nj. Hepatology. 2015 Jan;61(1):171-83. doi: 10.1002/hep.27380. Epub 2014 Nov 25. Hepatology. 2015. PMID: 25132062 Free PMC article.

2

Constitutively active Gq impairs gonadotropin-releasing hormone-induced intracellular signaling and luteinizing hormone secretion in LbetaT2 cells.

Liu F, Ruiz MS, Austin DA, Webster NJ. Liu F, et al. Among authors: webster nj. Mol Endocrinol. 2005 Aug;19(8):2074-85. doi: 10.1210/me.2004-0145. Epub 2005 May 5. Mol Endocrinol. 2005. PMID: 15878957

3

SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.

Sen S, Talukdar I, Webster NJ. Sen S, et al. Among authors: webster nj. Mol Cell Biol. 2009 Feb;29(3):871-80. doi: 10.1128/MCB.01709-08. Epub 2008 Dec 1. Mol Cell Biol. 2009. PMID: 19047369 Free PMC article.

4

Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.

Sen S, Talukdar I, Liu Y, Tam J, Reddy S, Webster NJ. Sen S, et al. Among authors: webster nj. J Biol Chem. 2010 Aug 13;285(33):25426-37. doi: 10.1074/jbc.M109.095224. Epub 2010 Jun 2. J Biol Chem. 2010. PMID: 20519504 Free PMC article.

5

hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.

Talukdar I, Sen S, Urbano R, Thompson J, Yates JR 3rd, Webster NJ. Talukdar I, et al. Among authors: webster nj. PLoS One. 2011;6(11):e27869. doi: 10.1371/journal.pone.0027869. Epub 2011 Nov 23. PLoS One. 2011. PMID: 22132154 Free PMC article.

6

Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function.

Sen S, Jumaa H, Webster NJ. Sen S, et al. Among authors: webster nj. Nat Commun. 2013;4:1336. doi: 10.1038/ncomms2342. Nat Commun. 2013. PMID: 23299886 Free PMC article.

7

Degradation of splicing factor SRSF3 contributes to progressive liver disease.

Kumar D, Das M, Sauceda C, Ellies LG, Kuo K, Parwal P, Kaur M, Jih L, Bandyopadhyay GK, Burton D, Loomba R, Osborn O, Webster NJ. Kumar D, et al. Among authors: webster nj. J Clin Invest. 2019 Aug 8;129(10):4477-4491. doi: 10.1172/JCI127374. J Clin Invest. 2019. PMID: 31393851 Free PMC article.

8

Alternative RNA Splicing in Fatty Liver Disease.

Wu P, Zhang M, Webster NJG. Wu P, et al. Front Endocrinol (Lausanne). 2021 Feb 26;12:613213. doi: 10.3389/fendo.2021.613213. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716968 Free PMC article. Review.

9

Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.

Kumar D, Das M, Oberg A, Sahoo D, Wu P, Sauceda C, Jih L, Ellies LG, Langiewicz MT, Sen S, Webster NJG. Kumar D, et al. Adv Sci (Weinh). 2022 Jul;9(21):e2105120. doi: 10.1002/advs.202105120. Epub 2022 May 26. Adv Sci (Weinh). 2022. PMID: 35615981 Free PMC article.

10

GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells.

Liu F, Austin DA, Mellon PL, Olefsky JM, Webster NJ. Liu F, et al. Among authors: webster nj. Mol Endocrinol. 2002 Mar;16(3):419-34. doi: 10.1210/mend.16.3.0791. Mol Endocrinol. 2002. PMID: 11875099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page